» Articles » PMID: 18087123

Pre-transplant Calcium-phosphate-parathormone Homeostasis As a Risk Factor for Early Graft Dysfunction

Overview
Date 2007 Dec 19
PMID 18087123
Citations 5
Authors
Affiliations
Soon will be listed here.
Abstract

While good organ quality and ideal transplant conditions eliminate many of the know factors that compromise initial graft function (IGF), poor early graft function (EGF) still occurs after living donor kidney transplantation (LDKT). Uncontrolled pre-transplant hypercalcemia and hyperparathyroidism are associated with impaired allograft function. Between April 2004 and January 2006, data were collected on 354 LDKT recipients including 252 males and 102 females, to determine risk factors for poor EGF, defined as either delayed or slow graft function (DGF or SGF). Of the 354 recipients, 318 (89%) had IGF, 22 (6.2%) had SGF and 14 (4%) had DGF. Donor female gender (P = 0.04) and duration on dialysis (P = 0.02) were associated with poor EGF. Recipients with DGF had higher serum phosphate (P = 0.07) and calcium x phosphate product ( P = 0.01) than recipients with IGF and SGF. The serum parathormone (PTH) levels were higher in recipients with SGF and DGF although the difference was not statistically significant (P = 0.1). Serum calcium levels did not correlate with the occurrence of poor EGF (P = 0.9). Our study suggests that serum phosphate and calcium x phosphate product serve as risk factors for DGF while serum PTH level may play a role as a risk factor for SGF and DGF.

Citing Articles

Prognostic value of preoperative serum alkaline phosphatase for predicting 3-year mortality in patients undergoing kidney transplantation: A retrospective study.

Yoon H, Ko D, Nam S, Song Y, Yun B, Ham S PLoS One. 2022; 17(8):e0273662.

PMID: 36037177 PMC: 9423622. DOI: 10.1371/journal.pone.0273662.


Increasing rates of parathyroidectomy to treat secondary hyperparathyroidism in dialysis patients with Medicare coverage.

Mathur A, Ahn J, Sutton W, Zeiger M, Segev D, McAdams-DeMarco M Surgery. 2022; 172(1):118-126.

PMID: 35314072 PMC: 9233023. DOI: 10.1016/j.surg.2022.02.005.


Electrolytes Disturbance and Cyclosporine Blood Levels among Kidney Transplant Recipients.

Einollahi B, Nemati E, Rostami Z, Teimoori M, Ghadian A Int J Organ Transplant Med. 2014; 3(4):166-75.

PMID: 25013642 PMC: 4089299.


Association of pre-kidney transplant markers of mineral and bone disorder with post-transplant outcomes.

Molnar M, Kovesdy C, Mucsi I, Salusky I, Kalantar-Zadeh K Clin J Am Soc Nephrol. 2012; 7(11):1859-71.

PMID: 22956265 PMC: 3488942. DOI: 10.2215/CJN.01910212.


Mineral abnormalities and long-term graft function in pediatric renal transplant recipients: a role for FGF-23?.

Wesseling-Perry K, Tsai E, Ettenger R, Juppner H, Salusky I Nephrol Dial Transplant. 2011; 26(11):3779-84.

PMID: 21441401 PMC: 3247799. DOI: 10.1093/ndt/gfr126.